CANC Holdings Information

CANC is an equity ETF with a total of 59 individual holdings. The top holdings are Revolution Medicines stock at 4.96%, AstraZeneca at 4.61%, Novartis AG at 4.45%, Roche Holding AG at 4.27%, and Eli Lilly and Company at 4.20%.

Total Holdings

Top 10 Percentage

41.00%

Asset Class

Equity

ETF Category

Health

Assets

160.25M

PE Ratio

19.80

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	4.96%	85,622
2	LON: AZN	AstraZeneca PLC	4.61%	38,059
3	SWX: NOVN	Novartis AG	4.45%	47,589
4	RHHBY	Roche Holding AG	4.27%	139,823
5	LLY	Eli Lilly and Company	4.20%	7,588
6	BBIO	BridgeBio Pharma, Inc.	3.95%	91,081
7	COGT	Cogent Biosciences, Inc.	3.88%	175,515
8	BMY	Bristol-Myers Squibb Company	3.75%	100,366
9	MRK	Merck & Co., Inc.	3.62%	49,112
10	IMNM	Immunome, Inc.	3.31%	274,099
11	JNJ	Johnson & Johnson	3.23%	21,341
12	NUVL	Nuvalent, Inc.	3.21%	53,067
13	CELC	Celcuity Inc.	3.07%	45,428
14	GMAB	Genmab A/S	2.95%	182,924
15	ABBV	AbbVie Inc.	2.72%	20,397
16	CGON	CG Oncology, Inc.	2.51%	62,752
17	EXEL	Exelixis, Inc.	2.51%	95,631
18	AMGN	Amgen Inc.	2.37%	10,881
19	FXFXX	First American Treasury Obligations Fund	2.26%	3,616,498
20	IDYA	IDEAYA Biosciences, Inc.	2.19%	111,577
21	ERAS	Erasca, Inc.	2.10%	225,398
22	ZLAB	Zai Lab Limited	2.04%	182,494
23	ONC	BeOne Medicines AG	2.02%	11,361
24	LEGN	Legend Biotech Corporation	1.93%	178,283
25	ZYME	Zymeworks Inc.	1.58%	104,247

Showing 25 of 59 holdings

Subscribe to see the full list

Activate Now

As of Mar 30, 2026